These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Current cost analysis in the management of diabetes mellitus]. Oberender P Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S110-4; discussion S124-6. PubMed ID: 18686219 [TBL] [Abstract][Full Text] [Related]
25. Sitagliptin: a novel drug for the treatment of type 2 diabetes. Choy M; Lam S Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385 [TBL] [Abstract][Full Text] [Related]
26. [Diabetes drug therapy in the elderly person]. Barrou Z; Brihier M Soins Gerontol; 2009; (76):34-6. PubMed ID: 19366024 [No Abstract] [Full Text] [Related]
27. From educated guess to accepted practice: the use of oral antidiabetic agents in pregnancy. Langer O Clin Obstet Gynecol; 2007 Dec; 50(4):959-71. PubMed ID: 17982339 [TBL] [Abstract][Full Text] [Related]
28. Diabetes: the latest trends in glycemic control. Giurini JM; Cook EA; Cook JJ Clin Podiatr Med Surg; 2007 Apr; 24(2):159-89. PubMed ID: 17430766 [TBL] [Abstract][Full Text] [Related]
29. [Clinical studies that have influenced the treatment of diabetes]. Olsovský J Vnitr Lek; 2009 Apr; 55(4):349-53. PubMed ID: 19449748 [TBL] [Abstract][Full Text] [Related]
30. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight. Pi-Sunyer FX Postgrad Med; 2008 Jul; 120(2):5-17. PubMed ID: 18654064 [TBL] [Abstract][Full Text] [Related]
31. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study. Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976 [TBL] [Abstract][Full Text] [Related]
32. Exenatide: a novel incretin mimetic agent for treating type 2 diabetes mellitus. Lam S; See S Cardiol Rev; 2006; 14(4):205-11. PubMed ID: 16788334 [TBL] [Abstract][Full Text] [Related]
33. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus. Spellman CW J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of diabetes mellitus with oral antidiabetics]. Berger W Ther Umsch; 1967 Aug; 24(8):318-26. PubMed ID: 5589654 [No Abstract] [Full Text] [Related]
35. Exercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy. Gulve EA Phys Ther; 2008 Nov; 88(11):1297-321. PubMed ID: 18801852 [TBL] [Abstract][Full Text] [Related]
36. Recent and emerging anti-diabetes targets. Mohler ML; He Y; Wu Z; Hwang DJ; Miller DD Med Res Rev; 2009 Jan; 29(1):125-95. PubMed ID: 18855890 [TBL] [Abstract][Full Text] [Related]
37. A review on the actual trends of insulin treatment in elderly with diabetes. Motta M; Bennati E; Ferlito L; Passamonte M; Cardillo E; Malaguarnera M Arch Gerontol Geriatr; 2008; 47(1):151-61. PubMed ID: 17913262 [TBL] [Abstract][Full Text] [Related]
38. [The treatment of diabetes in the aged with the oral antidiabetic drug Redul]. Jansen W Med Monatsschr; 1965 Jun; 19(6):280-1. PubMed ID: 5318643 [No Abstract] [Full Text] [Related]
39. [Treatment with oral antidiabetics]. Tidsskr Nor Laegeforen; 1971 Aug; 91(21):1555-8. PubMed ID: 5569818 [No Abstract] [Full Text] [Related]
40. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities. Malesker MA Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]